Agendia has hired Neil Barth to be its chief medical officer. Barth has 35 years of experience as a physician and in genomic biomarker development, and he led a staff of 1,400 physicians at Hoag Hospital in Newport Beach, Calif.
Enzo Biochem's shareholders have re-elected Gregory Bortz and Dov Perlysky to serve on the company's board of directors for three-year terms.
Bortz is founder and managing partner of Creo Capital Partners and he previously was senior VP of the Investment Banking Division of Lehman Brothers. Perlysky has been a managing member of the private investment firm Nesher and a director of the mutual fund Engex, and he has served on the board of directors at Pharma-Bio Serv and Highlands Bancorp.